Bendamustine as part of conditioning of autologous stem cell transplantation in patients with aggressive lymphoma: a phase 2 study from the GELTAMO group
Alba M. Redondo, David Valcárcel, Ana P. González-Rodríguez, María Suárez-Lledó, José L. Bello, Miguel Canales, Jorge Gayoso, Mercedes Colorado, Isidro Jarque, Raquel del Campo, Reyes Arranz, María J. Terol, José J. Rifón, María J. Rodríguez, María J. Ramírez, Nerea Castro, Andrés Sánchez, Javier López-Jiménez, Santiago Montes-Moreno, Javier BrionesAurelio López, Luis Palomera, Armando López-Guillermo, Dolores Caballero, Alejandro Martín
Profundice en los temas de investigación de 'Bendamustine as part of conditioning of autologous stem cell transplantation in patients with aggressive lymphoma: a phase 2 study from the GELTAMO group'. En conjunto forman una huella única.